Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6258739rdf:typepubmed:Citationlld:pubmed
pubmed-article:6258739lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:6258739lifeskim:mentionsumls-concept:C0596208lld:lifeskim
pubmed-article:6258739lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:6258739lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:6258739lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:6258739lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:6258739lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:6258739pubmed:issue2lld:pubmed
pubmed-article:6258739pubmed:dateCreated1981-5-26lld:pubmed
pubmed-article:6258739pubmed:abstractTextThe binding kinetics of angiotensin II (ANG II) have been studied in primary cultures from fetal rat brain. Binding of [125I]ANG II to rat brain cells in culture is time-, pH- and cell concentration-dependent. The binding is saturable, reversible, and 90--95% specific. Binding follows first-order kinetics, with values for K1 and K-1 of 4.9 x 10(6)M-1 S-1 and 3.33 x 10(4)S-1 respectively. Scatchard analysis reveals the presence of a single class of binding sites with Ka of 1.0 x 10(9)M-1 and an average of approximately 6 x 10(3) sites per cell. [125I]ANG II recovered from incubation medium under the conditions of the binding assay or after dissociation from cells is not significantly degraded as judged by gel filtration on Sephadex G-25 and radioreceptor assay. ANG II analogs compete with [125I]ANG II for binding, with potencies in general paralleling previously established biological activities. Of 5 analogs tested, (Ile8)-ANG II was almost equipotent with ANG II while (Dval3)-ANG II was least potent in the competitive binding assay. These data fulfill criteria for the identification of specific angiotensin II receptors in cells from mammalian brain.lld:pubmed
pubmed-article:6258739pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6258739pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6258739pubmed:languageenglld:pubmed
pubmed-article:6258739pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6258739pubmed:citationSubsetIMlld:pubmed
pubmed-article:6258739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6258739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6258739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6258739pubmed:statusMEDLINElld:pubmed
pubmed-article:6258739pubmed:monthMarlld:pubmed
pubmed-article:6258739pubmed:issn0006-8993lld:pubmed
pubmed-article:6258739pubmed:authorpubmed-author:PhillipsM IMIlld:pubmed
pubmed-article:6258739pubmed:authorpubmed-author:RaizadaM KMKlld:pubmed
pubmed-article:6258739pubmed:authorpubmed-author:FellowsR ERElld:pubmed
pubmed-article:6258739pubmed:authorpubmed-author:YangJ WJWlld:pubmed
pubmed-article:6258739pubmed:issnTypePrintlld:pubmed
pubmed-article:6258739pubmed:day2lld:pubmed
pubmed-article:6258739pubmed:volume207lld:pubmed
pubmed-article:6258739pubmed:ownerNLMlld:pubmed
pubmed-article:6258739pubmed:authorsCompleteYlld:pubmed
pubmed-article:6258739pubmed:pagination343-55lld:pubmed
pubmed-article:6258739pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:meshHeadingpubmed-meshheading:6258739-...lld:pubmed
pubmed-article:6258739pubmed:year1981lld:pubmed
pubmed-article:6258739pubmed:articleTitleRat brain cells in primary culture: characterization of angiotensin II binding sites.lld:pubmed
pubmed-article:6258739pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6258739pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed